These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10671957)

  • 1. Carbenoxolone effects in congenital adrenal hyperplasia.
    Walker BR; Stewart PM
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):246-8. PubMed ID: 10671957
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I; Cutler GB
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward better treatment of congenital adrenal hyperplasia.
    Speiser PW
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):273-4. PubMed ID: 10469004
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
    Nordenström A; Marcus C; Axelson M; Wedell A; Ritzén EM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1210-3. PubMed ID: 10199755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids, kidneys, sweet roots and dirty drugs.
    Monder C
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C95-8. PubMed ID: 1936517
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
    Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
    Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquorice.
    Teelucksingh S; Benediktsson R; Lindsay RS; Burt D; Seckl JR; Edwards CR; Nan CL; Kelly R
    Lancet; 1991 Jun; 337(8756):1549. PubMed ID: 1675399
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental congenital lipoid adrenal hyperplasia: prevention of anatomic defects produced by aminoglutethimide.
    Goldman AS
    Endocrinology; 1970 Nov; 87(5):889-93. PubMed ID: 5529931
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    Andrews RC; Rooyackers O; Walker BR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Mammary gland defects in experimental congenital adrenal hyperplasia due to inhibition to 3 beta-hydroxysteroid dehydrogenase in rats.
    Neumann F; Goldman AS
    Endocrinology; 1970 May; 86(5):1169-71. PubMed ID: 4314068
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of congenital adrenocortical hyperplasia in rats by estradiol-17-beta and inhibition of 3-beta-hydroxysteroid dehydrogenase.
    Goldman AS
    J Clin Endocrinol Metab; 1968 Feb; 28(2):231-8. PubMed ID: 5688816
    [No Abstract]   [Full Text] [Related]  

  • 12. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
    Morris DJ; Souness GW
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring.
    Lindsay RS; Lindsay RM; Edwards CR; Seckl JR
    Hypertension; 1996 Jun; 27(6):1200-4. PubMed ID: 8641724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.
    Andrew R; Smith K; Jones GC; Walker BR
    J Clin Endocrinol Metab; 2002 Jan; 87(1):277-85. PubMed ID: 11788660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
    Young MJ; Moussa L; Dilley R; Funder JW
    Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
    Ulick S; Wang JZ; Hanukoglu A; Rösler A
    J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of steroid-11-beta hydroxylase deficiency].
    Sólyom J; Cholnoky P; Helmuth D; Dietrich K; Nagy E; Varga I; Gláz E
    Orv Hetil; 1986 Sep; 127(36):2171-5. PubMed ID: 3463925
    [No Abstract]   [Full Text] [Related]  

  • 18. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
    Best R; Walker BR
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):231-6. PubMed ID: 9302399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and fetal effects of two inhibitors of 3 beta-hydroxysteroid dehydrogenase and delta 5-4,3-ketosteroid isomerase in the rat.
    Goldman AS
    Endocrinology; 1969 Aug; 85(2):325-9. PubMed ID: 5784921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.